Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|September 1, 1991
Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assaysL M Weisenthal, D H KernJournal of the National Cancer Institute|April 4, 1990
Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposuresD H Kern, L M WeisenthalCancer Treatment Reports|June 1, 1985
Clonogenic and nonclonogenic in vitro chemosensitivity assaysL M Weisenthal, M E LippmanJournal of Internal Medicine|September 17, 2008
Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral bloodL M Weisenthal, N Patel, C Rueff-WeisenthalJournal of Clinical Gastroenterology|June 1, 1983
Delayed hemorrhage after percutaneous liver biopsyC M Reichert, L M Weisenthal, H G KleinJournal of the National Cancer Institute|January 2, 1991
Effect of prior cancer chemotherapy on human tumor-specific cytotoxicity in vitro in response to immunopotentiating biologic response modifiersL M Weisenthal, P L Dill, F C PearsonCancer|April 15, 1983
In vitro chemosensitivity of human bladder cancerL M Weisenthal, A O Lalude, J B MillerCancer Treatment Reports|June 1, 1987
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasmsY Z Su, T E Duarte, P L Dill, et al.Cancer Research|January 1, 1983
Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicityL M Weisenthal, P L Dill, N B Kurnick, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissuesR A Nagourney, J C Messenger, D H Kern, et al.Pageof 2